Part,  Chapter, Paragraph

 1   II,     5.  5.  3|         Fleischhacker W, Parsch JR, Ebenbichler C (2006): Antipsychotic
 2   II,     5.  5.  3|        262:37-44.~Errea JM, Ara JR, Aibar C, de Pedro-Cuesta
 3   II,     5.  5.  3|    MacMahon DG, Peto V, Playfer JR (2003): Direct economic
 4   II,     5.  6.  6|  Company Limited, Sydney~Center JR, Nguyen TV, Schneider D,
 5   II,     5.  6.  6|        DA, Wigley FM, Scott WW, Jr., Hochberg MC, Tobin JD (
 6   II,     5.  6.  6| Simonsick EM, Kashner TM, Hebel JR, Kenzora JE (1990): Predictors
 7   II,     5.  8.  7|         Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner
 8   II,     5. 10.  7|        JO'B, Cornelisse-Vermaat JR, Frewer L, Mills C, AEJ
 9   II,     9.  3.  1|     Snow, V Shekelle, P Hopkins Jr R. Forciea, MA Owens, DK (
10  III,    10.  1.  3|         114:2739-2752.~Marshall JR (1994): The diagnosis and
11  III,    10.  2.  1|      338-344.~ ~Paffenbarger RS JR et al (1994): Changes in
12  III,    10.  2.  1|        Mesana MI, Fleta J, Ruiz JR, González-Gross M, Sarría
13  III,    10.  2.  1|         259.~ ~Brown KM, Arthur JR (2001): Selenium, selenoproteins
14  III,    10.  2.  4|  Rollinson S, Bracci PM, Cerhan JR, Whitby D, Moore PS, Leaderer